[1]顾华香,程验,李鹏飞,等.干细胞在泪膜为导向型干眼治疗中作用的研究进展[J].眼科新进展,2023,43(11):903-906.[doi:10.13389/j.cnki.rao.2023.0181]
 GU Huaxiang,CHENG Yan,LI Pengfei,et al.Advances in the role of stem cells in tear film-oriented therapy for dry eye[J].Recent Advances in Ophthalmology,2023,43(11):903-906.[doi:10.13389/j.cnki.rao.2023.0181]
点击复制

干细胞在泪膜为导向型干眼治疗中作用的研究进展/HTML
分享到:

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
43卷
期数:
2023年11期
页码:
903-906
栏目:
文献综述
出版日期:
2023-11-05

文章信息/Info

Title:
Advances in the role of stem cells in tear film-oriented therapy for dry eye
作者:
顾华香程验李鹏飞张国伟季敏管怀进
226001 江苏省南通市,南通大学医学院,南通大学附属医院眼科
Author(s):
GU HuaxiangCHENG YanLI PengfeiZHANG GuoweiJI MinGUAN Huaijin
Medical School of Nantong University,Department of Ophthalmology,the Affiliated Hospital of Nantong University,Nantong 226001,Jiangsu Province,China
关键词:
干眼泪膜干细胞
Keywords:
dry eye tear film stem cell
分类号:
R777.34
DOI:
10.13389/j.cnki.rao.2023.0181
文献标志码:
A
摘要:
干眼(DE)是一种以泪膜不稳定为主要特征的多因素慢性疾病,常伴有干涩、异物、视物模糊和视疲劳等临床症状,中重度DE还可导致眼表损伤进而引起视力障碍。目前,DE主要采用人工泪液替代等传统对症治疗方法。近年来,大量科研工作致力于寻找DE的新型疗法,以期修复受损的泪腺、副泪腺、睑板腺和结膜杯状细胞等外分泌腺的结构与功能,继而恢复各层泪液的分泌,维持泪膜的稳定性。干细胞因其多能分化特性已成为再生医学领域重要的种子细胞。由于人眼结构与生理功能的独特性,眼组织再生是再生医学研究最活跃的领域。本文主要围绕干细胞在DE再生治疗中的研究进展进行综述。
Abstract:
Dry eye (DE) is a multifactorial chronic disease characterized by tear film instability, often accompanied by dryness, foreign body sensation, blurred vision and visual fatigue. Moderate to severe DE can lead to ocular surface damage and visual impairment. At present, DE is mainly treated according to symptoms, for example, with artificial tear replacement. In recent years, a lot of research has been made to find new DE therapies, which are expected to repair the structure and function of damaged exocrine glands, such as lacrimal glands, accessory lacrimal glands, meibomian glands and conjunctival goblet cells, promote the secretion of tear, and maintain the stability of tear films. Due to their pluripotent differentiation, stem cells have become important seed cells in the field of regenerative medicine. Human eyes are unique in structure and physiological function; thus, eye tissue regeneration is of the most concern in the field of regenerative medicine. This article reviews the latest research on the role of stem cells in DE regenerative therapy.

参考文献/References:

[1] TSUBOTA K,YOKOI N,SHIMAZAKI J,WATANABE H,DOGRU M,YAMADA M,et al.New perspectives on dry eye definition and diagnosis:a consensus report by the asia dry eye society[J].Ocul Surf,2017,15(1):65-76.
[2] TSUBOTA K,YOKOI N,WATANABE H,DOGRU M,KOJIMA T,YAMADA M,et al.A new perspective on dry eye classification:Proposal by the asia dry eye society[J].Eye Contact Lens,2020,46 Suppl(1):S2-S13.
[3] ROONEY G E,NISTOR G I,BARRY F B,KEIRSTEAD H S.In vitro differentiation potential of human embryonic versus adult stem cells[J].Regen Med,2010,5(3):365-379.
[4] MITTAL R,PATEL S,GALOR A.Alternative therapies for dry eye disease[J].Curr Opin Ophthalmol,2021,32(4):348-361.
[5] BARNSTABLE C J,JONAS J B,ZHANG K.Regenerative medicine,advanced stem cell,and gene therapies for eye diseases[J].Asia Pac J Ophthalmol (Phila),2022,11(4):299-301.
[6] BOBBA S,DI GIROLAMO N,MUNSIE M,CHEN F,PEBAY A,HARKIN D,et al.The current state of stem cell therapy for ocular disease[J].Exp Eye Res,2018,177:65-75.
[7] YOKOI N,BRON A J,GEORGIEV G A.The precorneal tear film as a fluid shell:the effect of blinking and saccades on tear film distribution and dynamics[J].Ocul Surf,2014,12(4):252-266.
[8] MCDONALD J E,BRUBAKER S.Meniscus-induced thinning of tear films[J].Am J Ophthalmol,1971,72(1):139-146.
[9] YOKOI N,GEORGIEV G A.Tear film-oriented diagnosis and tear film-oriented therapy for dry eye based on tear film dynamics[J].Invest Ophthalmol Vis Sci,2018,59(14):DES13-DES22.
[10] BAUDOUIN C,ROLANDO M,BENITEZ DEL CASTILLO J M,MESSMER E M,FIGUEIREDO F C,IRKEC M,et al.Reconsidering the central role of mucins in dry eye and ocular surface diseases[J].Prog Retin Eye Res,2019,71:68-87.
[11] SHIMAZAKI-DEN S,DOGRU M,HIGA K,SHIMAZAKI J.Symptoms,visual function,and mucin expression of eyes with tear film instability[J].Cornea,2013,32(9):1211-1218.
[12] SPEAKMAN S,WANG M T M,MUNTZ A,VIDAL-ROHR M,MENDUNI F,DHALLU S,et al.Investigating the diagnostic utility of non-invasive tear film stability and breakup parameters:a prospective diagnostic accuracy study[J].Ocul Surf,2022,25:72-74.
[13] RHEE J,CHAN T C,CHOW S S,DI ZAZZO A,INOMATA T,SHIH K C,et al.A systematic review on the association between tear film metrics and higher order aberrations in dry eye disease and treatment[J].Ophthalmol Ther,2022,11(1):35-67.
[14] KAIDO M.Functional visual acuity[J].Invest Ophthalmol Vis Sci,2018,59(14):DES29-DES35.
[15] MA S,YU Z,FENG S,CHEN H,CHEN H,LU X.Corneal autophagy and ocular surface inflammation:a new perspective in dry eye[J].Exp Eye Res,2019,184:126-134.
[16] KIJLSTRA A,KUIZENGA A.Analysis and function of the human tear proteins[J].Adv Exp Med Biol,1994,350:299-308.
[17] PFLUGFELDER S C,DE PAIVA C S.The pathophysiology of dry eye disease:what we know and future directions for research[J].Ophthalmology,2017,124(11S):S4-S13.
[18] BRON A J,DE PAIVA C S,CHAUHAN S K,BONINI S,GABISON E E,JAIN S,et al.TFOS DEWS II pathophysiology report[J].Ocul Surf,2017,15(3):438-510.
[19] WILLCOX M D P,ARGUESO P,GEORGIEV G A,HOLOPAINEN J M,LAURIE G W,MILLAR T J,et al.TFOS DEWS II tear film report[J].Ocul Surf,2017,15(3):366-403.
[20] HAMRAH P,QAZI Y,SHAHATIT B,DASTJERDI M H,PAVAN-LANGSTON D,JACOBS D S,et al.Corneal nerve and epithelial cell alterations in corneal allodynia:an in vivo confocal microscopy case series[J].Ocul Surf,2017,15(1):139-151.
[21] BELMONTE C,NICHOLS J J,COX S M,BROCK J A,BEGLEY C G,BEREITER D A,et al.TFOS DEWS II pain and sensation report[J].Ocul Surf,2017,15(3):404-437.
[22] SOIFER M,AZAR N S,MOUSA H M,PEREZ V L.Ocular surface inflammatory disorders (osid):a collective of systemic etiologies which cause or amplify dry eye syndrome[J].Front Med (Lausanne),2022,9:949202.
[23] DIETRICH J,OTT L,ROTH M,WITT J,GEERLING G,MERTSCH S,et al.Msc transplantation improves lacrimal gland regeneration after surgically induced dry eye disease in mice[J].Sci Rep,2019,9(1):18299.
[24] GROMOVA A,VORONOV D A,YOSHIDA M,THOTAKURA S,MEECH R,DARTT D A,et al.Lacrimal gland repair using progenitor cells[J].Stem Cells Transl Med,2017,6(1):88-98.
[25] TSENG S C,HIRST L W,MAUMENEE A E,KENYON K R,SUN T T,GREEN W R.Possible mechanisms for the loss of goblet cells in mucin-deficient disorders[J].Ophthalmology,1984,91(6):545-552.
[26] SHATOS M A,RIOS J D,HORIKAWA Y,HODGES R R,CHANG E L,BERNARDINO C R,et al.Isolation and characterization of cultured human conjunctival goblet cells[J].Invest Ophthalmol Vis Sci,2003,44(6):2477-2486.
[27] NOMI K,HAYASHI R,ISHIKAWA Y,KOBAYASHI Y,KATAYAMA T,QUANTOCK A J,et al.Generation of functional conjunctival epithelium,including goblet cells,from human ipscs[J].Cell Rep,2021,34(5):108715.
[28] ZHONG Z,DENG X,WANG P,YU C,KIRATITANAPORN W,WU X,et al.Rapid bioprinting of conjunctival stem cell micro-constructs for subconjunctival ocular injection [J].Biomaterials,2021,267:120462.
[29] YAN D,YAN C,YU F,ZHANG S,CHEN L,WU N,et al.Exploitation of human mesenchymal stromal cell derived matrix towards the structural and functional restoration of the ocular surface[J].Biomater Sci,2020,8(17):4712-4727.
[30] BRON A J,TIFFANY J M,GOUVEIA S M,YOKOI N,VOON L W.Functional aspects of the tear film lipid layer[J].Exp Eye Res,2004,78(3):347-360.
[31] AMANO S.Meibomian gland dysfunction:recent progress worldwide and in Japan[J].Invest Ophthalmol Vis Sci,2018,59(14):DES87-DES93.
[32] HWANG H S,PARFITT G J,BROWN D J,JESTER J V.Meibocyte differentiation and renewal:Insights into novel mechanisms of meibomian gland dysfunction (mgd)[J].Exp Eye Res,2017,163:37-45.
[33] TCHEGNON E,LIAO C P,GHOTBI E,SHIPMAN T,WANG Y,MCKAY R M,et al.Epithelial stem cell homeostasis in meibomian gland development,dysfunction,and dry eye disease[J].JCI Insight,2021,6(20):e151078.
[34] PARFITT G J,LEWIS P N,YOUNG R D,RICHARDSON A,LYONS J G,DI GIROLAMO N,et al.Renewal of the holocrine meibomian glands by label-retaining,unipotent epithelial progenitors[J].Stem Cell Reports,2016,7(3):399-410.
[35] OLAMI Y,ZAJICEK G,COGAN M,GNESSIN H,PE’ER J.Turnover and migration of meibomian gland cells in rats’ eyelids[J].Ophthalmic Res,2001,33(3):170-175.
[36] KNOP E,KNOP N,MILLAR T,OBATA H,SULLIVAN D A.The international workshop on meibomian gland dysfunction:Report of the subcommittee on anatomy,physiology,and pathophysiology of the meibomian gland[J].Invest Ophthalmol Vis Sci,2011,52(4):1938-1978.

相似文献/References:

[1]姜洋 李莹 王忠海 罗岩 金玉梅.小牛血去蛋白提取物眼用凝胶对LASIK 术后角膜修复及干眼的疗效观察[J].眼科新进展,2012,32(7):000.
[2]叶芬 王春红 陈银 施宇华 黄振平.人工泪液对糖尿病干眼患者泪河的影响[J].眼科新进展,2012,32(12):000.
[3]皮百木 穆红梅 张婉婷 郑娜 李娟.老年干眼患者眼表改变及其与睑板腺功能障碍的相关性[J].眼科新进展,2013,33(6):000.
[4]邵毅 高桂平 余瑶 邹文进 裴重刚 李凯军 涂萍 杨继玲 陈素芳.带状疱疹病毒性角膜炎非活动期眼表改变的临床研究[J].眼科新进展,2013,33(7):000.
[5]张宏 马俊旗 安晓 叶向彧.围绝经期干眼患者眼表CXCR3表达与性激素的相关性分析[J].眼科新进展,2013,33(9):000.
[6]董雯佳 裴重刚 邵毅 周琼 易敬林 刘新华 李汉林.个性化显微斜视矫正术矫正儿童斜视的临床研究[J].眼科新进展,2012,32(2):000.
[7]魏瑞华 郝永娜 赵少贞.自身免疫相关性干眼动物模型的研究进展[J].眼科新进展,2012,32(7):000.
[8]田凯琳 邢怡桥 贺涛 杨安怀.23G和20G玻璃体切割术后泪膜和眼表变化的对比研究[J].眼科新进展,2012,32(9):000.
[9]张虹 胡竹林.超声乳化术对高度近视合并年龄相关性白内障患者泪膜稳定性及泪液蛋白的影响[J].眼科新进展,2013,33(3):000.
[10]魏瑞华 郝永娜 边领斋 李雪 粘红 赵少贞.Sjogren综合征相关性干眼发病机制的研究进展[J].眼科新进展,2013,33(3):000.
[11]张磊 何彦津.无眼征Graves病患者的眼表损害[J].眼科新进展,2012,32(12):000.
[12]叶芬 田农 施宇华 薛春燕 黄振平.糖尿病干眼患者的波前像差分析[J].眼科新进展,2012,32(4):000.
[13]毛祖红 王乐 邵毅 张广斌 叶向彧 陈乐磊 董诺.不同方位切口对角膜神经损伤及泪膜功能影响相关性研究[J].眼科新进展,2013,33(12):000.
[14]潘玥吉,贾卉.角膜移植术后干眼的研究进展[J].眼科新进展,2015,35(11):1094.[doi:10.13389/j.cnki.rao.2015.0300]
 PAN Yue-Ji,JIA Hui.Research progress on dry eye after keratoplasty[J].Recent Advances in Ophthalmology,2015,35(11):1094.[doi:10.13389/j.cnki.rao.2015.0300]
[15]章成芝,徐青.同轴微切口白内障超声乳化术后泪膜及角膜规则性的研究[J].眼科新进展,2016,36(6):559.[doi:10.13389/j.cnki.rao.2016.0148]
 ZHANG Cheng-Zhi,XU Qing.Changes in tear film and corneal surface regularity after coaxial micro-incision phacoemulsification[J].Recent Advances in Ophthalmology,2016,36(11):559.[doi:10.13389/j.cnki.rao.2016.0148]
[16]杨斐,李孝纯,于洋,等.白内障术毕结膜囊应用黏弹剂对患者术后早期干眼的预防效果[J].眼科新进展,2022,42(1):058.[doi:10.13389/j.cnki.rao.2022.0013]
 YANG Fei,LI Xiaochun,YU Yang,et al.Effect of applying an ophthalmic viscosurgical device in conjunctival sac at the end of cataract surgery in alleviating early postoperative dry eye[J].Recent Advances in Ophthalmology,2022,42(11):058.[doi:10.13389/j.cnki.rao.2022.0013]

备注/Memo

备注/Memo:
国家自然科学基金资助项目(编号:81974129,82171038)
更新日期/Last Update: 2023-11-05